Objectives: Preoperative anemia has been related with adverse outcomes in elective valve replacement and CABG surgery. Impact of preoperative anemia on outcome in octogenarians submitted to cardiopulmonary bypass (CPB) has not yet been precisely described. Methods: We analyzed association between preoperative hemoglobin level, minimum intraoperative and immediate postoperative hematocrit (HCT), and other co-morbidities and occurrence of adverse outcomes in 227 octogenarians who underwent cardiac surgery. Results: Frequency of preoperative anemia was 41.9% (40.4% in male and 43.5% in female patients). Postoperative mortality was 13.2% (9% in nonanemic patients vs. 18.9% in anemic). 44.5% of patients suffered at least one postoperative adverse outcome (43.1% non-anemic vs. 46.3% anemic). In multivariate analysis (after adjusting independent preoperative risk factors for operative mortality and EuroSCORE) preoperative creatinin level wodds ratio (OR), 2.29; 95% confidence interval (CI), 1.06-4.98; Ps0.035x, immediate postoperative HCT -24% (OR, 2.78; 95% CI, 1.04-7.38; Ps0.039), perioperative red blood cell (RBC) transfusion (OR, 1.58; 95% CI, 1.24-2.00; Ps0.0001), peripheral vascular disease (OR, 4.92; 95% CI, 1.45-16.69; Ps0.012) and urgent surgery (OR, 10.57; 95% CI, 2.54-43.91; Ps0.0001) were identified as independent predictors for in-hospital mortality. Conclusions: Mortality and adverse postoperative outcome increase in anemic octogenarians undergoing cardiac surgery. Although mortality is directly related to immediate postoperative anemia, adverse outcomes mainly depend on associated co-morbidities.
Introduction
According to the World Health Organization (WHO), anemia is defined as hemoglobin level under 12 mgydl in women and 13 mgydl in men w1x, or lower than 2 standard deviation (S.D.) regarding to mean levels in reference population w2x. Anemia is a documented independent risk factor for mortality in the elderly w2, 3x and in patients affected by heart failure w4, 5x. Some studies involving patients who underwent cardiac surgery with cardiopulmonary bypass (CPB) have demonstrated that morbimortality, perioperative acute myocardial infarction (AMI) and adverse event rates, are higher in anemic patients w6-10x.
Anemia in the elderly can be a surrogate marker of chronic or inflammatory disease w2x. Commonly well tolerated in young patients, its presence in the elderly during CPB can trigger secondary vasodilatation and subsequent renal and cerebral hypoperfusion. So far, no studies evaluating influence of preoperative anemia on results of cardiac surgery with CPB in octogenarian patients have been published.
Methods
Between January 2000 and October 2008, 246 consecutive patients aged over 80 years underwent cardiac surgery. We evaluate the influence of preoperative anemia on results of cardiac surgery with CPB. Records for 13 patients operated without CPB and six patients who underwent technical problems andyor severe intraoperative hemorrhage were excluded from the analysis, in order to reduce potential confounding factors disabling the aim of the study. Final study group was composed by 227 patients. According to WHO criteria, we classified octogenarian patients into two groups: Group A (anemic patients) and Group B (nonanemic patients).
Demographic and clinical data, information regarding procedure and perioperative endpoints, were collected prospectively. In-hospital mortality was defined as 30-day mortality. During the postoperative period, we considered as adverse events: low cardiac output, atrial fibrillation (AF), perioperative AMI, renal failure, respiratory failure, 
Results
Preoperative risk factors, operative and biochemical data in groups A and B appear in Tables 1 and 2 . 41.9% of patients showed preoperative anemia (40.4% of male patients and 43.5% of female patients).
Risk factors for preoperative anemia in octogenarians
25.9% of the patients presented preoperative hypoalbuminemia (albumin -3.6 mgydl) (18.75% in Group B and 36.36% in Group A). Multivariate analysis showed significant association between hypoalbuminemia and anemia (OR, 2.75; 95% CI, Ps0.038) .
In Group A, hyponatremia (Na -135 mEqyl) was detected in 7% of the patients and preoperative renal failure (creatinin G2 mgydl) was diagnosed in 9.47%. Neither hyponatremia nor renal failure were identified as significant risk factors for anemia in multivariate analysis (Ps0.925 and Ps0.093, respectively).
In 50 recently operated patients, C-reactive protein (CRP) was preoperatively determinated. Values over reference ones were identified in 64% of patients, but only in 34% belonging to Group A. There was no significant association between higher preoperative CRP values and anemia (Ps0.869).
No other risk factors were identified in association with preoperative anemia.
In-hospital mortality
In-hospital mortality was 13.2% (9% in Group B vs. 18.9% in Group A). Causes of in-hospital mortality were cardiac failure (40.6%), multiorgan failure (18.8%), sepsis (15.6%), respiratory failure (12.5%), neurological complications (6.3%), mesenteric ischemia (3.1%) and pulmonary thromboembolism (3.1%). Independent significant risk factors for mortality in multivariate analysis appear in Table 3 . Y. Carrascal et al. / Interactive CardioVascular and Thoracic Surgery 10 (2010) 
Postoperative complications
44.5% of the patients presented postoperative complications (43.1% in Group B vs. 46.3% in Group A). Table 4 shows the incidence of postoperative complications in each group. In Table 3 , independent risk factors for most frequently reported complications are referred. No variables were independently associated with perioperative AMI or surgical wound infection. Incidence of postoperative complications was not influenced by low HCT during CPB or during the immediate postoperative period.
In regard to hemoderivatives transfusion, multivariate analysis revealed that Groups II and III had a significantly higher rate of postoperative respiratory failure than Group I. Besides, transfusion of 4 or more RBC units (Group III) is associated to increased postoperative incidence of low cardiac output.
Hospital stay
Hospital and ICU stay were longer, but not significantly different. Hospital stay was 15.65"14.52 vs. 3.64" 10.61 days (Ps0.23) and ICU stay was 7.25"10.73 vs. 4.95"8.01 days (Ps0.069) in Groups A and B, respectively.
Incremental risk factors for perioperative transfusion
Preoperative anemia was not an independent risk factor for perioperative transfusion (Ps0.931) and no other significant risk factor could be identified in multivariate analysis. In univariate analysis, RBC transfusion in octogenarian patients after CPB depends more on minimum HCT during CPB than on HCT immediately after surgery. Immediate postoperative HCT in transfused patients was 24.67"3.46% vs. 25.68"4.17% in non-transfused ones (Ps0.052). However, minimum HCT during CPB was significantly lower in patients who needed transfusion (21.28"3.27 vs. 22.19"3.44) (Ps0.045).
Mortality during follow-up
We conducted a median follow-up of 32 months (interval, 2-104 months) in 97.5% of the patients. Mortality during follow-up was 20.8%. Causes of mortality were cardiac failure (25.7%), infectionysepsis (14.3%), CVA (17.1%), chronic obstructive pulmonary disease (COPD) exacerbation (8.6%), neoplasm (5.7%), coagulopathyyhemorrhage (5.7%) and unknown (11.4%). Survivals at one, three and five years (excluding in-hospital mortality) were 88.23, 81.91 and 70.19%, respectively. No significant differences in overall survival between Groups A and B were identified (Ps0.874) (Fig. 1) . 72.6% of the patients were in NYHA functional class I or II during follow-up. In multivariate analysis preoperative anemia, minimum HCT during CPB and lower immediate postoperative HCT level (-24%) were not significantly associated to mortality during follow-up ( Table  5) . Survival according to transfusion groups is detailed in Fig. 2 . No significant differences were observed, even considering in-hospital mortality. Mortality was 18.34% in Group I, 31.14% in Group II and 22.72% in Group III. When comparing survival between different groups, the values of P were: Group I and II (Ps0.081), Group II and III (Ps0.499) and Group I and III (Ps0.052).
Discussion
Incidence of anemia increases progressively beyond 50 years, even in healthy people w11, 12x. 17-18% of healthy persons aged over 80 years living at home, and 24-53% of hospitalized ones, suffer anemia w13x. In hospitalized elderly, overall prevalence of anemia was higher in men than in women (15-67.3% male vs. 11-41% female) w14x. More than 20% of people aged over 85 years suffer anemia, increasing up to 48-63% if they are hospitalized w3, 11, 14x.
Etiology of anemia is related, in one-third of cases, to a global malnutrition or nutritional deficits affecting iron, folic acid or vitamin B12. Another third of anemias are due to inflammatory diseases, renal failure or neoplasm, and the cause is unknown in the remaining third w11, 14x. Several risk factors were found to be associated with anemia: advanced age, male sex, previous AMI and CVA, peripheral vascular disease, diabetes mellitus, neoplasm and left ventricular dysfunction w5, 7, 9, 14x. Multiple studies conclude that anemia (even slight) in healthy elderly adults, increases mortality w2x, risk of cardiac and renal failure and need of hospitalization and may contribute to cognitive and functional impairment w3, 5, 11, 13-15x. However, no report has, up to now, quantified these effects in the context of cardiac surgery with CPB.
In the population we analyzed, prevalence of anemia does not differ from other reports referred to hospitalized octogenarians (41.9%) w3, 13, 14x but we find is slightly higher in female patients w5, 14x. In our sample, the most important risk factor related to preoperative anemia was hypoalbuminemia. Although 40.9% of patients with preoperative renal failure and 60% of those with hyponatremia (Na-135 mEqyl) had anemia (which might relate anemia to cardio-renal disease), none of these factors was identified as an independent risk factor in multivariate analysis. The subgroup of 50 patients in which preoperative CRP was determined, showed a high amount of inflammatory activity in octogenarians (up to 64% of the cases) but only in onehalf was associated to anemia. So, although its origin might be multifactorial, carential etiology seems to predominate in our group over inflammatory or cardio-renal disease secondary to cardiac failure.
In patients undergoing cardiac surgery, an increased risk of early and late mortality and perioperative complications associated with preoperative anemia and low HCT during CPB has been reported w6, 10, 16, 17x. In addition, the need of perioperative transfusion is associated with increased in-hospital mortality w18x, infection w19x and low cardiac output w20x. Long-term survival after cardiac surgery is, also, significantly diminished w21, 22x.
In our population, in-hospital mortality doubles in patients with preoperative anemia, but it was not a significant predictor in multivariate analysis. However, in-hospital mortality is associated with immediate postoperative HCT -24% and perioperative RBC transfusion.
Anemia induces modifications in oxygen tissular distribution and secondarily, tissular hypoxia and lactic acidosis. Compensatory mechanism produces hyperdynamic circulation and vasodilatation w11x, increasing stroke volume and heart rate. Diverse studies have demonstrated a limited ability to compensate anemia in patients with cardiac failure w5x. Better tolerated in young population, vasodilatation secondary to anemia can lead to inadequate cerebral and renal perfusion in elderly patients w23x. Probably, HCT decreasing under 24% during immediate postoperative period, favors tissular hypoxia in target organs as lung, kidney or heart, and impairs its functional recovery after CPB. This effect can be more relevant in octogenarians because of age-associated subclinical deterioration and is independent of preoperative-postoperative HCT difference. In consequence, maneuvers focussed on guaranteeing careful hemostasis and minimizing phlebotomies during this period are mandatory.
Although surgical pathology in our sample is heterogenic (coronary bypass grafting and valvular surgery population are both included) and the 'hemoglobin demand' seems apparently different (because jeopardized ischemic myocardium in coronary disease patients could be more susceptible to the perioperative anemic condition), we have not identified in octogenarians significative differences, secondary to cardiac disease etiology, in analyzed end-points.
As in young patients, we have observed an increasing inhospital mortality after CPB associated with the number of units of RBC transfused w17, 18, 24x. In octogenarians, transfusional requirement is more related to low HCT during CPB than to decreased HCT immediately after surgical procedure. No in-depth information regarding the moment of RBC transfusion was collected. Relationship between probability of transfusion and low HCT during CPB we have shown, and this led us to suspect that transfusion should have been intraoperative. Consequently, intraoperative dilutional anemia (identified as an independent risk factor for in-hospital mortality) w7, 10x, may be masked in our population, in which low immediate postoperative HCT (-24%) is a significant predictor for in-hospital mortality.
Unlike previous reports w8, 9x, we have not observed a different incidence of postoperative complications related with preoperative anemia or hemodilution during CPB. Only preoperative anemia, with hemoglobin level inferior to 11 gydl, is close to be a significant risk factor for postoperative respiratory failure. Besides, RBC transfusion significantly increases the risk of respiratory failure, ICU stay (5.08"3.38 days in Group II vs. 24.20"19 .08 days in Group III) (Ps0.011) and postoperative low cardiac output. With the aim of reducing RBC transfusion, measures directed to decrease hematic loss during surgical procedure might be effective: avoidance of using CPB, reduction of CPB prime volume, or use of reduced circuits wMinimal extracorporeal circulation circuit (MECC) systemx and utilization of autologous blood recovery and reinfusion systems. These measures can be complemented, in case of preoperative anemia, with iron and folic substitutive therapies or erythropoietin administration before surgery.
In our population, during CPB, mean of minimum HCT was 21.87% (range: 18-36%). Although a minimum HCT superior to 22-24% is recommended for elderly patients during CPB, in order to avoid tissular oxygenation compromise w10x, we have not observed a direct relationship between low HCT during CPB and major neurological complications, renal failure, perioperative AMI or low cardiac output.
Mortality during follow-up was significantly higher in diabetics and in patients with preoperative renal failure and postoperative respiratory failure. Opposed to the results of Koch et al. w21x and Engoren et al. w22x , neither anemia nor need of blood transfusion (independently of units of RBC) decreased survival.
Study limitations
This analysis considered a limited number of octogenarians undergoing cardiac surgery and results are not readily generalizable to all elderly population. Most previous studies analyzing the potential risk generated by preoperative anemia in cardiac surgery included only coronary bypass surgery w7, 10, 20-22x. Our selected group gave us information about the influence of anemia in octogenarians undergoing valvular and coronary surgery with CPB. Up to now, no data about this subject have been published.
No information about the moment of transfusion (intraor postoperative, before hospital discharge) have been requested. So, transfusion was not randomly assigned and multivariate analysis may not adequately control for confounding and bias. We cannot discern if the effects of hemodilution during CPB on in-hospital mortality are masked by intraoperative transfusion in our population. Prospective studies are needed to quantify if the effects on in-hospital mortality are higher because of hemodilution during CPB or liberal transfusional policy.
Conclusions
Prevalence of anemia in octogenarians undergoing cardiac surgery is over 40%. Although anemia contributes to increasing in-hospital mortality and postoperative complications, it is not an independent risk factor for in-hospital mortality that, in this population, depends more on HCT after CPB. In this population, measures should be focused on avoiding HCT decrease below critical level (24%) after CPB.
Transfusions increase risk of in-hospital mortality and respiratory failure after cardiac surgery.
Octogenarians are more frequently affected by preoperative anemia and, in this group, probability of tissular hypoxia because hemodilution during and immediately after CPB is higher. It may seem that a more liberal transfusion policy is mandatory in the elderly population, however, our results pointed out that the objective is to try to keep very low groups of transfused octogenarians despite preoperative anemia, because the risk factor is transfusion and not preoperative anemia.
